Literature DB >> 22358571

To the editor.

J R Yannelli1, A M Bastin, M Jadus.   

Abstract

Year:  1988        PMID： 22358571     DOI： 10.1007/BF00146820

Source DB:  PubMed          Journal:  Cytotechnology        ISSN： 0920-9069            Impact factor:   2.058


× No keyword cloud information.
  4 in total

1.  On lymphokines, cytokines, and breakthroughs.

Authors:  C G Moertel
Journal:  JAMA       Date:  1986-12-12       Impact factor: 56.272

2.  An improved method for the generation of human lymphokine activated killer cells.

Authors:  J R Yannelli; G B Thurman; S G Dickerson; A Mrowca; E Sharp; R K Oldham
Journal:  J Immunol Methods       Date:  1987-06-26       Impact factor: 2.303

3.  A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

Authors:  S A Rosenberg; M T Lotze; L M Muul; A E Chang; F P Avis; S Leitman; W M Linehan; C N Robertson; R E Lee; J T Rubin
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

4.  Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer.

Authors:  W H West; K W Tauer; J R Yannelli; G D Marshall; D W Orr; G B Thurman; R K Oldham
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.